QeA to EU Commission – Protecting coeliac consumers and gluten-free logos

Question for written answer to the Commission Giovanni La Via (PPE) - 18th February 2016 Subject:  Products containing gluten: protecting coeliac consumers Coeliac disease is an auto-immune disorder that affects 1% of the European population, in which the immune system can cause malabsorption and increases the risk of nutrient deficiencies, anaemia and osteoporosis, given that … Continue reading QeA to EU Commission – Protecting coeliac consumers and gluten-free logos

FDA Proposes Limit for Inorganic Arsenic in Infant Rice Cereal

The US Food and Drug Administration (FDA) is taking steps to reduce inorganic arsenic in infant rice cereal, a leading source of arsenic exposure in infants. Through a draft guidance to industry, the FDA is proposing a limit or “action level” of 100 parts per billion (ppb) for inorganic arsenic in infant rice cereal. FDA … Continue reading FDA Proposes Limit for Inorganic Arsenic in Infant Rice Cereal